Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from AstraZeneca

FTSE 100 chief executive pay reaches highest level on record

Bosses of UK’s biggest companies are now paid 120 times more than average full-time worker in some instances

The Guardian - UK

AstraZeneca Says It Has A 'Powerful' — And Differentiated — Approach To Obesity Treatment

AstraZeneca stock skidded Thursday despite strong quarterly sales as an FDA panel met to discuss its lung cancer treatment.

Investors Business Daily

What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients

A renaissance is stirring in cholesterol treatment, and it could drive Merck, Novartis and other stocks higher, while delivering new choices for millions of patients.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks

There hasn't been a new COPD treatment in years. But Regeneron stock analysts are closely watching a pair of key FDA decisions.

Investors Business Daily

Meet The International Megacaps That 'Match Or Surpass' Magnificent Seven Stocks

These five companies may offer higher earnings and return potential with lower risk. Two Leaderboard stocks included.

Investors Business Daily

1 Biopharma Stock Setting the New Standard in Cancer Care Drugs

The annual conference of the American Society of Clinical Oncology is always the biggest event-making cancer conference. And this year, the attention-grabber was AstraZeneca, as its lung and breast cancer drugs significantly slowed the spread of disease in two trials, potentially establishing the medicines as the new standard of care…

Barchart

Is the British Gas boss really worth £8.2m?

The share price recovery has been partly driven by the surge in wholesale energy prices, which is beyond his control

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Urgent call for breast cancer drug to stop women’s lives being cut short

Women with HER2-low incurable secondary disease in Scotland currently have access, while others across the UK do not

The Independent UK

Will AstraZeneca be the UK’s first £200bn company?

The former pharma laggard is in a race with Shell to be the first FTSE 100 stock to be valued at £200bn

The Guardian - UK

FTSE 100 Live 21 May: Inflation in focus after index closes slightly down

Higher-than expected UK inflation figures disappointed the City today, with shares falling as the 2.3% Consumer Price Index reading dashed hopes of a June interest rate cut.

Evening Standard

AstraZeneca aims to nearly double revenues to $80bn by 2030

UK’s biggest drugmaker says it plans to launch 20 major new medicines before the end of the decade

The Guardian - UK

'New era of growth': AstraZeneca sets out bold plans for $80bn revenues by 2030

The growth will be fuelled by 20 new drugs that are set to launch this decade

Evening Standard

Tyson Fury and Mo Salah outearn Europe’s highest paid CEOs—but top U.S. execs trail only Cristiano Ronaldo's $260 million haul

Stellantis CEO Carlos Tavares had a compensation package worth $39.4 million in 2023, lower than any of the world's top 50 sports stars.

Fortune

Doctors group raises concerns over Covishield vaccine side effects

A group of doctors under the banner of Awaken India Movement (AIM) have raised concerns over the side effects of Covishield vaccine in the wake of pharmaceutical giant AstraZeneca admitting in a U.K. court that its vaccine can cause blood clots in rare cases.

The Hindu

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Forget Weight-Loss Drugs, Here's the Next Breakthrough Pharma Stock

There is another segment of the pharma industry that is as hot as weight-loss drugs: antibody-drug conjugates, or ADCs. These treatments will, in the near future, replace conventional chemotherapy, thanks to fewer side effects for patients. Even a partial replacement for chemotherapy could make it a $140 billion market -…

The Guardian - UK

AstraZeneca’s Covid vaccine is no more – but its remarkable success must not be forgotten

Although dogged by controversy, the firm’s coronavirus jab saved the lives of millions and helped avert humanitarian crises in nations unable to access costly alternatives

Investors Business Daily

Catalyst's New CEO Has Big Ideas For The Small Biotech

Richard Daly has watched Catalyst Pharmaceuticals transform. Now, as the company's new CEO, he has some metamorphic ideas of his own.

The Hindu

Covishield side effects | Doctors’ group urges Centre to review all COVID vaccines

Doctors express concern over Covishield vaccine safety due to potential blood clot side effects, urging government review and action.

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

Chemicals in flavoured vapes potentially ‘very toxic when heated’ - Tech & Science Daily

New research suggests chemicals in flavoured vapes could be highly toxic when heated.

Top News

Astrazeneca Withdraws Vaxzevria Vaccine Due To Decline In Demand

AstraZeneca withdraws Vaxzevria vaccine due to decreased demand from newer, more effective mRNA vaccines. Strategic shift in global vaccination landscape.

Kiplinger

How to Find the Best European Stocks To Buy

European stocks are cheaper than their U.S. counterparts, and there are plenty of high-quality companies to choose from. Here's how to find them.

Evening Standard

AstraZeneca withdraws Covid vaccine worldwide due to 'surplus'

The pharma giant says the decision was made due to the availability of superior vaccines

International Business Times

AstraZeneca Withdraws Covid Vaccine As Demand Dives

Anglo-Swedish drugmaker AstraZeneca on Wednesday said it was withdrawing Covid vaccine Vaxzevria, one of the first produced in the deadly pandemic, citing "commercial reasons" following a slump in demand.

The Guardian - AU

Afternoon Update: US paused weapons shipment to Israel; Hunter Valley bus driver plea deal; and the life expectancy of cats

Senior US official says shipment of bombs was paused last week after review of weapons that might be used in Rafah

Dynamite News

AstraZeneca withdraws COVID-19 vaccine worldwide, cites commercial reasons

The pharmaceutical giant AstraZeneca's COVID-19 vaccine is being withdrawn worldwide after the company acknowledged for the first time in court documents that it can cause a rare and dangerous side effect, according to a report in the British Newspaper 'The Telegraph'. Read further on Dynamite News:

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

International Monetary Fund

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.